O-21 - HIV Treatment and Complications

Co-Author(s)

• RA

  Reina Armamento-Villareal, MD

  Associate Professor
  Endocrinology
  Baylor College of Medicine
  Houston, Texas

  Disclosure: I do not have any relevant financial / non-financial relationships with any proprietary interests.
• CB

  Christiana Blair, MS

  Director
  Biostatistics
  Gilead Sciences Inc.
  Foster City, California

  Disclosure: Gilead Sciences (Employee, Shareholder)
• RB

  Ronald Bosch, PhD

  Principal Research Scientist
  Harvard TH Chan School of Public Health
  Boston, Massachusetts

  Disclosure: I do not have any relevant financial / non-financial relationships with any proprietary interests.
• KB

  Katharine Breaux, PA

  Assistant Professor
  Infectious Diseases
  Baylor College of Medicine
  Houston, Texas

  Disclosure: I do not have any relevant financial / non-financial relationships with any proprietary interests.
• SC

  Silvia Chang, Masters

  Associate Scientist
  Gilead Sciences
  Foster City, California

  Disclosure: Gilead Sciences (Employee, Shareholder)
• 

  Eva Clark, MD, PhD

  Assistant Professor
  Baylor College of Medicine
  Houston, TX

  Disclosure: I do not have any relevant financial / non-financial relationships with any proprietary interests.
• AC

  Ann Collier, MD

  Professor of Medicine
  University of Washington
  Seattle, Washington

  Disclosure: I do not have any relevant financial / non-financial relationships with any proprietary interests.
• SC

  Sean Collins, MD, MS

  Senior Director
  Virology
  Gilead Sciences
  Foster CIty, California

  Disclosure: Gilead Sciences (Employee)
• JC

  Joshua Cyktor, PhD

  Research Assistant Professor of Medicine
  University of Pittsburgh
  Pittsburgh, Pennsylvania

  Disclosure: I do not have any relevant financial / non-financial relationships with any proprietary interests.
• 

  Michelle D'Antoni, PhD

  Research Scientist
  Gilead Sciences Inc
  Foster City, California

  Disclosure: Gilead Sciences (Employee, Shareholder)
• 

  Joseph Eron, MD

  Professor
  Medicine
  University of North Carolina at Chapel Hill
  Chapel Hill, North Carolina

  Disclosure: Gilead Sciences (Consultant, Research Grant or Support)Janssen (Consultant, Research Grant or Support)Merck (Consultant)ViiV Healthcare (Consultant, Research Grant or Support)
• SH

  Spencer Harpe, PharmD, PhD, MPH, FAPhA

  Professor of Pharmacy Administration
  Pharmacy Practice
  Midwestern University - Chicago College of Pharmacy
  Downers Grove, Illinois

  Disclosure: I do not have any relevant financial / non-financial relationships with any proprietary interests.
• LH

  Lucas Hill, PharmD

  Pharmacist Specialist - HIV and Hepatitis C
  University of California San Diego Health
  San Diego, California

  Disclosure: I do not have any relevant financial / non-financial relationships with any proprietary interests.
• MK

  Maile Karris, MD

  Associate Clinical Professor, Medicine
  University of California San Diego Health
  San Diego, California

  Disclosure: I do not have any relevant financial / non-financial relationships with any proprietary interests.
• GL

  Gregory Laird, PhD

  Co-Founder
  Accelevir Diagnostics
  Baltimore, Maryland

  Disclosure: Accelevir Diagnostics (Shareholder, Other Financial or Material Support, Employee)
• BM

  Bernard Macatangay, MD

  Assistant Professor of Medicine
  University of Pittsburgh
  Pittsburgh, Pennsylvania

  Disclosure: Gilead (Grant/Research Support)
• HM

  Hanna Mar, MSPH

  Biostatistician
  Harvard TH Chan School of Public Health
  Boston, Massachusetts

  Disclosure: I do not have any relevant financial / non-financial relationships with any proprietary interests.
• AM

  Albine Martin, PhD

  Co-Founder
  Accelevir Diagnostics
  Baltimore, Maryland

  Disclosure: Accelevir Diagnostics (Shareholder, Other Financial or Material Support, Employee)
• DM

  Deborah McMahon, MD

  Professor of Medicine
  University of Pittsburgh
  Pittsburgh, Pennsylvania

  Disclosure: I do not have any relevant financial / non-financial relationships with any proprietary interests.
• JM

  John Mellors, MD

  Professor of Medicine
  University of Pittsburgh
  Pittsburgh, Pennsylvania

  Disclosure: Abound Bio (Shareholder)Accelevir Diagnostics (Consultant)Co-Crystal Pharmaceuticals (Shareholder)Gilead (Consultant, Grant/Research Support)Merck (Consultant)
• AP

  Aiyappa Parvangada, MS Computational Biology

  Sr. Bioinformatics Associate I
  Employee
  San Mateo, California

  Disclosure: Gilead Sciences (Employee)
• HQ

  Huifang Qin, PhD

  Senior Clinical Data Analyst
  University of California San Diego Health
  San Diego, California

  Disclosure: I do not have any relevant financial / non-financial relationships with any proprietary interests.
• SR

  Sharon Riddler, MD

  Associate Professor of Medicine
  University of Pittsburgh
  Pittsburgh, Pennsylvania

  Disclosure: I do not have any relevant financial / non-financial relationships with any proprietary interests.
• CR

  Charles Rinaldo, PhD

  Professor and Chair, Infectious Diseases and Microbiology; Professor, Pathology
  University of Pittsburgh
  Pittsburgh, Pennsylvania

  Disclosure: I do not have any relevant financial / non-financial relationships with any proprietary interests.
• MR

  Maria Rodriguez- Barradas, MD

  Professor
  Baylor College of Medicine
  Houston, Texas

  Disclosure: I do not have any relevant financial / non-financial relationships with any proprietary interests.
• JS

  Janet Siliciano, PhD

  Associate Professor of Medicine
  Johns Hopkins University School of Medicine
  Baltimore, Maryland

  Disclosure: Gilead (Advisor or Review Panel member)US Military HIV Research Program (Advisor or Review Panel member)
• CT

  Christie Turin, MD

  Endocrinology Fellow
  Baylor College of Medicine
  Houston, Texas

  Disclosure: I do not have any relevant financial / non-financial relationships with any proprietary interests.
• KW

  Kirsten White, PhD

  Sr. Director
  Biology
  Gilead Sciences, Inc.
  Foster City, California

  Disclosure: Gilead Sciences, Inc. (Employee, Shareholder)

Presenting Author(s)

• 

  Kristen Andreatta, MSc

  Sr Associate Scientist
  Gilead Sciences, Inc
  Foster City, CA

  Disclosure: Gilead Sciences (Employee, Shareholder)

  Slides Slides and Audio
• 

  Julia Darnell, PharmD

  Pharmacy Resident
  UCSD
  La Jolla, CA

  Disclosure: I do not have any relevant financial / non-financial relationships with any proprietary interests.

  Slides Slides and Audio
• 

  Rajesh Gandhi, MD

  Professor of Medicine
  Harvard Medical School
  Boston, Massachusetts

  Disclosure: I do not have any relevant financial / non-financial relationships with any proprietary interests.

  Slides Slides and Audio
• 

  Naveed Khanjee, MD

  Fellow Physician
  Internal Medicine
  UT Southwestern Medical Center
  Dallas, TX

  Disclosure: I do not have any relevant financial / non-financial relationships with any proprietary interests.

  Slides Slides and Audio
• 

  Milena Murray, PharmD, MSc, BCIDP, AAHIVP

  Associate Professor
  Pharmacy Practice
  Midwestern University - Chicago College of Pharmacy
  Downers Grove, Illinois

  Disclosure: Merck (Speaker's Bureau)

  Slides Slides and Audio

Presentations:

• META-INSTI: Metabolic Adverse Events Following Integrase Strand Transfer Inhibitor Administration in Spontaneous Adverse Event Reports
  Milena M. Murray, PharmD, MSc, BCIDP, AAHIVP – Midwestern University - Chicago College of Pharmacy; Spencer E. Harpe, PharmD, PhD, MPH, FAPhA – Midwestern University - Chicago College of Pharmacy
• Impact of Switching to an Antiretroviral Regimen Containing Tenofovir Alafenamide on Weight Gain and Development of Metabolic Side Effects
  Julia Darnell, PharmD – UCSD; Maile Karris, MD – University of California San Diego Health; Huifang Qin, PhD – University of California San Diego Health; Lucas Hill, PharmD – University of California San Diego Health
• Selective Decay of Intact HIV-1 Proviral DNA on Antiretroviral Therapy
  Rajesh Gandhi, MD – Harvard Medical School; Joshua Cyktor, PhD – University of Pittsburgh; Ronald Bosch, PhD – Harvard TH Chan School of Public Health; Hanna Mar, MSPH – Harvard TH Chan School of Public Health; Gregory Laird, PhD – Accelevir Diagnostics; Albine Martin, PhD – Accelevir Diagnostics; Ann Collier, MD – University of Washington; Sharon Riddler, MD – University of Pittsburgh; Bernard Macatangay, MD – University of Pittsburgh; Charles Rinaldo, PhD – University of Pittsburgh; Joseph J. Eron, MD – University of North Carolina at Chapel Hill; Janet Siliciano, PhD – Johns Hopkins University School of Medicine; Deborah McMahon, MD – University of Pittsburgh; John Mellors, MD – University of Pittsburgh
• preexisting Resistance and Week 48 Virologic Outcomes After Switching to B/F/TAF in African American Adults with Hiv
  Kristen Andreatta, MSc – Gilead Sciences, Inc; Michelle L. D'Antoni, PhD – Gilead Sciences Inc; Silvia Chang, Masters – Gilead Sciences; Aiyappa Parvangada, MS Computational Biology – Employee; Christiana Blair, MS – Gilead Sciences Inc.; Sean E. Collins, MD, MS – Gilead Sciences; Kirsten L. White, PhD – Gilead Sciences, Inc.
• Bone Mineral Density Screening in Veterans Living with HIV
  Naveed Khanjee, MD – UT Southwestern Medical Center; Christie G. Turin, MD – Baylor College of Medicine; Katharine Breaux, PA – Baylor College of Medicine; Reina Armamento-Villareal, MD – Baylor College of Medicine; Maria Rodriguez- Barradas, MD – Baylor College of Medicine; Eva Clark, MD, PhD – Baylor College of Medicine